pipette
ESEspañol

Frequency of pharmacogenomic variation and medication exposures among participants in the All of Us Research Program

Andrew Haddad, Aparna Radhakrishnan, Sean R. McGee, Joshua D. Smith, Jason H. Karnes, Eric Venner, Marsha M. Wheeler, Karynne Patterson, Kimberly Walker, Divya Kalra, Sara E. Kalla, Qiaoyan Wang, Kathleen Polkowski, Richard A. Gibbs, Gail Pairitz Jarvik, Janeth I. Sanchez, Anjene Musick Addington, Andrea H. Ramirez, Joshua C. Denny, Philip E. Empey, Dmitry Abramov, Brian Ahmedani, Habib Ahsan, Hoda Anton-Culver, Maria Argos, Dave W. Arnold, Brisa Aschebook-Kilfoy, Katie Baca-Motes, Catherine Balthazar, Laura Bartlett, Gillian Bartlett‐Esquilant, Melissa Basford, Leland Baskin, Mark Begale, Eric Boerwinkle, Ingrid Bonilla-Mercado, Alexander Borowsky, Amaryllis Silva Boschetti, Matthew Breeden, Brad Bryan, Jessica Burke, Elizabeth Burnside, Lisa Cadmus-Bertram, Librada Callender, Roberta Carlin, Olveen Carrasquillo, Suchitra Chandrasekaran, Alexander Charney, Mine Cicek, Cheryl Clark and 10 more

Peer-reviewed journalReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Importantly, we report thousands of previously unrecognized pharmacogene variants and hundreds of alleles and predicted phenotypes that deviate from known frequencies across populations or were previously unreported, especially in the Americas and African ancestry groups.

Appeared: Friday, November 13. Science Translational Medicine. Peer-reviewed journal.

DOI: 10.1126/scitranslmed.adt8040